{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:28:49Z","timestamp":1648715329275},"reference-count":10,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,4]]},"DOI":"10.1182\/blood.2020006079","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:46:53Z","timestamp":1591314413000},"page":"2018-2020","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Children with WAS: prefer early transplant!"],"prefix":"10.1182","volume":"135","author":[{"given":"Tayfun","family":"G\u00fcng\u00f6r","sequence":"first","affiliation":[{"name":"University Children\u2019s Hospital Zurich\u2013Eleonore Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"23","key":"2020060411312284900_B1","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood.2019002939","article-title":"Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report","volume":"135","author":"Burroughs","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2020060411312284900_B2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2020060411312284900_B3","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2020060411312284900_B4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2016.158808","article-title":"A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome","volume":"102","author":"Shekhovtsova","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"2020060411312284900_B5","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/S2352-3026(19)30021-3","article-title":"Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1\/2 clinical study","volume":"6","author":"Ferrua","year":"2019","journal-title":"Lancet Haematol"},{"issue":"8","key":"2020060411312284900_B6","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bbmt.2018.03.029","article-title":"High incidence of autoimmune disease after hematopoietic stem cell transplantation for chronic granulomatous disease","volume":"24","author":"Yanir","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2020060411312284900_B7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2019.06.039","article-title":"Platelets are the Achilles\u2019 heel of Wiskott-Aldrich syndrome","volume":"144","author":"Fischer","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2020060411312284900_B8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbmt.2014.11.674","article-title":"Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab","volume":"21","author":"Willemsen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2020060411312284900_B9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bbmt.2018.03.006","article-title":"A conditioning regimen with plerixafor is safe and improves the outcome of TCR\u03b1\u03b2+ and CD19+ cell-depleted stem cell transplantation in patients with Wiskott-Aldrich syndrome","volume":"24","author":"Balashov","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2020060411312284900_B10","doi-asserted-by":"crossref","first-page":"e27092","DOI":"10.1002\/pbc.27092","article-title":"Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome","volume":"65","author":"Yue","year":"2018","journal-title":"Pediatr Blood Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/23\/2018\/1743298\/bloodbld2020006079c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/23\/2018\/1743298\/bloodbld2020006079c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:47:00Z","timestamp":1591314420000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/135\/23\/2018\/458149\/Children-with-WAS-prefer-early-transplant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":10,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,6,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020006079","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]}}}